Upcoming Earnings: Q3 '26
Estimated EPS
-$0.06
Estimated Rev
$1.63M
• Reported GAAP EPS of -$0.06 up 40.00% YoY • Reported revenue of $1.2M down -0.83% YoY
Bullish Takeaway
Lucid Diagnostics has received Medicare payments at $1,938.01 per test from Irving claims, secured Concerts first positive EsoGuard coverage policy, and reported real-world EsoCheck collection success of 94.7%.
Bearish Takeaway
Lucid Diagnostics Q3 revenue was flat, operating loss was $12.28M; management disclosed substantial doubt about one-year continuity amid operating cash use, and Nasdaq identified sub-$1 noncompliance and possible delisting.
Generated by Stocktwits using AI and company-reported earnings data for Q3 '26. This recap is intended to help readers understand the quarter quickly. Verify key figures in the linked source materials; the summary may contain errors and is not investment advice.
Historical Earnings
Quarterly
Annual
EPS
Revenue
| Fiscal Period | Estimated | Reported | Surprise | Result |
|---|---|---|---|---|
Q3 '26 | -$0.06 | -- | -- | N/A |
Q2 '26 | -$0.06 | -$0.06 | -5.88% | MISSED |
Q1 '26 | -$0.05 | -$0.07 | -27.27% | MISSED |
Q4 '25 | -$0.11 | -$0.10 | 9.09% | BEAT |
Q3 '25 | -$0.10 | -$0.10 | -- | EXPECTED |